Will Aerie Pharmaceuticals (AERI) Hold its Support Level?

Aerie Pharmaceuticals, Inc. (AERI) engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye… 

Take a look at the 1-year chart of Aerie (AERI) below with added notations…

See chart and continue reading at STOCKNEWS.com